HST Segment Growth Driven by AI and Semiconductor Markets
Health & Science Technologies (HST) net sales increased 14% YoY to $415.0M (12% organic), fueled by AI-driven demand for data center power, semiconductor markets, and space and defense.
At the archive date, IDEX CORP /DE/ was expected to release its Q3 2026 10-Q filing on October 27, 2026. Last quarter: IDEX Corporation reported Q2 FY2026 revenue of $920.6M (+6.4% YoY) and diluted EPS of $1.93 (+10.9% YoY), driven by strong demand in Health & Science Technologies and net gains from IEEPA tariff refunds.
EPS Estimate
$2.25
Revenue Estimate
$937.15M
Analyst consensus captured from Finnhub and Financial Modeling Prep. This archived preview is no longer updated with later results; see the IEX page for retained reports.
Drawn from management commentary in the Q2 2026 10-Q:
Health & Science Technologies (HST) net sales increased 14% YoY to $415.0M (12% organic), fueled by AI-driven demand for data center power, semiconductor markets, and space and defense.
Following a U.S. Supreme Court ruling invalidating IEEPA tariffs, IDEX collected refunds that reduced Cost of Sales by $22.0M and Net Sales by $14.7M (due to customer rebates), contributing a net $0.08 benefit to diluted EPS.
Segment net sales were led by HST at $415.0M (+14%), followed by Fluid & Metering Technologies at $317.1M (+2% YoY with flat volume), while Fire & Safety/Diversified Products fell 1% to $189.9M due to lower European rescue and dispensing demand.
Revenue
$920.6M
+6.38% YoY
EPS (Diluted)
$1.93
+10.92% YoY
Gross Margin
46.4%
+1.0 pts YoY
Operating Income
$199.9M
+6.39% YoY
Add IEX to your watchlist to keep its archived reports easy to find. New filing alerts are no longer sent.